Crossmark

Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

Crossref DOI link: https://doi.org/10.1186/s12885-019-5548-x

Published Online: 2019-04-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Takenami, Tsutomu

Maeda, Shimpei https://orcid.org/0000-0001-9344-6527
Karasawa, Hideaki

Suzuki, Takashi

Furukawa, Toru

Morikawa, Takanori

Takadate, Tatsuyuki

Hayashi, Hiroki

Nakagawa, Kei

Motoi, Fuyuhiko

Naitoh, Takeshi

Unno, Michiaki
License Information

Text and Data Mining valid from 2019-04-05
More Information

Article History

Received: 28 May 2018

Accepted: 28 March 2019

First Online: 5 April 2019

Ethics approval and consent to participate

: This study was approved by the Ethics committee of Tohoku University Graduate School of Medicine (Approval No: 2016–1-747). The requirement of informed consent was waived and an opt-out method was used due to the retrospective design of the study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.